Author: Hayes C. Nelson Chayama Kazuaki
Publisher: MDPI
E-ISSN: 1422-0067|17|3|280-280
ISSN: 1422-0067
Source: International Journal of Molecular Sciences, Vol.17, Iss.3, 2016-02, pp. : 280-280
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Serum levels of liver enzymes, such as alanine transaminase, aspartate transaminase, and α-fetoprotein, provide insight into liver function and are used during treatment of liver disease, but such information is limited. In the case of hepatocellular carcinoma (HCC), which is often not detected until an advanced stage, more sensitive biomarkers may help to achieve earlier detection. Serum also contains microRNAs, a class of small non-coding RNAs that play an important role in regulating gene expression. miR-122 is specific to the liver and correlates strongly with liver enzyme levels and necroinflammatory activity, and other microRNAs are correlated with the degree of fibrosis. miR-122 has also been found to be required for hepatitis C virus (HCV) infection, whereas other microRNAs have been shown to play antiviral roles. miR-125a-5p and miR-1231 have been shown to directly target hepatitis B virus (HBV) transcripts, and others are up- or down-regulated in infected individuals. MicroRNA profiles also differ in the case of HBV and HCV infection as well as between HBeAg-positive and negative patients, and in patients with occult
Related content
Hepatitis B Virus Infection, MicroRNAs and Liver Disease
By Sarkar Neelakshi Chakravarty Runu
International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. :